Jump to ContentJump to Main Navigation
5-Hydroxytryptamine in PsychiatryA Spectrum of Ideas$
Users without a subscription are not able to see the full content.

Merton Sandler, Alec Coppen, and Sara Harnett

Print publication date: 1991

Print ISBN-13: 9780192620118

Published to Oxford Scholarship Online: March 2012

DOI: 10.1093/acprof:oso/9780192620118.001.0001

Show Summary Details
Page of

PRINTED FROM OXFORD SCHOLARSHIP ONLINE (www.oxfordscholarship.com). (c) Copyright Oxford University Press, 2018. All Rights Reserved. Under the terms of the licence agreement, an individual user may print out a PDF of a single chapter of a monograph in OSO for personal use (for details see www.oxfordscholarship.com/page/privacy-policy).date: 15 December 2018

Serotonin in anxiety: evidence from animal models

Serotonin in anxiety: evidence from animal models

Chapter:
(p.177) 15. Serotonin in anxiety: evidence from animal models
Source:
5-Hydroxytryptamine in Psychiatry
Author(s):

Mike Briley

Philippe Chopin

Publisher:
Oxford University Press
DOI:10.1093/acprof:oso/9780192620118.003.0015

Benzodiazepines have been shown since the early 1970s to cause some reduction of 5-hydroxytryptamine (5-HT, serotonin) turnover, but in view of similar effects on other neurotransmitters these results did not generate any major interest in serotonin as a transmitter in anxiety. The probability of a close link between serotonin and anxiety was highlighted by the demonstration of the anxiolytic properties of buspirone. Buspirone has a variety of pharmacological activities involving serotonin, noradrenaline, and dopamine, but its anticonflict properties are lost after serotonergic lesion, suggesting the importance of serotonin in anxiety. The anxiolytic activity in man of two close derivatives of buspirone, gepirone and ipsapirone, both of which lack the dopaminergic component of buspirone, further implicated serotonin in the control of anxiety.

Keywords:   benzodiazepines, neurotransmitters, anticonflict properties, anxiolytic properties, serotonergic lesion, dopaminergic component

Oxford Scholarship Online requires a subscription or purchase to access the full text of books within the service. Public users can however freely search the site and view the abstracts and keywords for each book and chapter.

Please, subscribe or login to access full text content.

If you think you should have access to this title, please contact your librarian.

To troubleshoot, please check our FAQs , and if you can't find the answer there, please contact us .